A carregar...

Código QR

‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

Therapeutic innovations of potentially great clinical impact should embrace the overarching values of research accountability, data transparency and validation through the scientific peer-review process.

Na minha lista:

Detalhes bibliográficos
Publicado no:	Nat Immunol
Main Authors:	Mastellos, Dimitrios C., Blom, Anna M., Connolly, E. Sander, Daha, Mohamed R., Geisbrecht, Brian V., Ghebrehiwet, Berhane, Gros, Piet, Hajishengallis, George, Holers, V. Michael, Huber-Lang, Markus, Kinoshita, Taroh, Mollnes, Tom E., Montgomery, Robert A., Morgan, B. Paul, Nilsson, Bo, Pio, Ruben, Ricklin, Daniel, Risitano, Antonio M., Taylor, Ronald P., Mantovani, Alberto, Ioannidis, John P. A., Lambris, John D.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	2019
Assuntos:	Article
Acesso em linha:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7368001/ https://ncbi.nlm.nih.gov/pubmed/31562490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41590-019-0503-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!